Alprazolam Recall: Xanax XR 3 mg Viatris
Announced 2026-04-15 · FDA
The FDA is recalling Viatris Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count Rx bottles, distributed nationwide in the US. The recall is due to failed dissolution specifications. Lot# 8177156, Exp Date: 02/28/2027, is affected.
| Brand | Viatris, Inc. |
|---|---|
| Product | Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91 |
| Reason | Failed Dissolution Specifications |
| Severity | moderate |
| Distribution | US Nationwide. |
| Agency | FDA |
WHAT YOU SHOULD DO
- Check if you have Xanax XR 3 mg tablets from Lot# 8177156 with Exp Date 02/28/2027.
- Do not take or use the recalled tablets.
- Contact your pharmacist or healthcare provider for guidance on disposal, replacement, or refunds.
- If you have questions, contact Viatris or the FDA for instructions.
How to identify the recalled item
| Lot / date codes | Lot# 8177156, Exp Date: 02/28/2027 |
|---|---|
| Lot / date codes | Lot# 8177156, Exp Date: 02/28/2027 |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.